BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 18647529)

  • 1. [Asialofetuin-hTERT-TK/GCV targeted gene therapy and its bystander effect on HepG2].
    Yang CQ; Deng ZH; Liu Y; Liu JL; Cao Y
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jul; 16(7):509-13. PubMed ID: 18647529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An experimental study on targeting suicide gene therapy for lung cancer with HSV-TK driven by hTERT promoter].
    Wang YP; Tang XJ; Zhou QH; Che GW; Chen XH; Zhu DX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):701-5. PubMed ID: 19024294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study on selective killing effect of Hsv-tk/GCV driven by human telomerase catalytic subunit promoter on human lung cancer cell A549].
    Tang XJ; Wang YP; Zhou QH; Che GW; Chen XH; Zhu DX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr; 24(2):148-52. PubMed ID: 17407070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].
    Kong BH; Song Y; Ma DX; Qu X; Jiang S
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recombinant plasmid pEGFP-AFP-TK delivered by nano-magnetic fluids targeting killed AFP positive HepG2 cells in vitro].
    Luo Y; Zhang YD; Peng J; Yan HX; Xue D; Wu K; Zhou L; Hang SW; Zhao JF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 May; 25(5):437-9. PubMed ID: 19426602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cloning of human telomerase reverse transcriptase promoter for targeted cancer therapy].
    Li F; Tan XH; Peng XJ; Cai HB; Hu DR
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):207-11. PubMed ID: 15699008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of ovarian cancer cell line Skov3 with HSV-tk/GCV under the control of human telomerase reverse transcriptase gene promoter].
    Song Y; Kong BH; Liu PS; Ma DX; Qu X; Jiang S
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):438-42. PubMed ID: 12974091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transcriptional targeting gene therapy of double suicide gene driven by hTERT promoter in hepatic carcinoma].
    Fan WZ; Yang JY; Chen W; Huang YH; Wang Y; Zhang YQ; Li JP
    Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(43):3080-5. PubMed ID: 22333065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitory effect of polyethylenimine-mediated transfection of suicide gene HSV-tk with an ovarian-specific promoter on growth of ovarian cancer cell line SKOV3].
    Jin P; Kong BH
    Ai Zheng; 2005 Jul; 24(7):806-11. PubMed ID: 16004805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction of pGL3-hTERT-tk recombinant plasmid and effect of PEG-PEI/Fe(3)0(4) Nano-magnetic fluid-tk/GCV on proliferation of gastric cancer cells BGC823 in vitro].
    Buduwaili WS; Li L; Zhang BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Jul; 15(7):727-31. PubMed ID: 22851080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
    Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
    Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
    Majumdar AS; Hughes DE; Lichtsteiner SP; Wang Z; Lebkowski JS; Vasserot AP
    Gene Ther; 2001 Apr; 8(7):568-78. PubMed ID: 11319624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Killing effect of PNP/MeP-dR suicide gene system driven by an AFP promoter AF0.3 on AFP-positive hepatoma cells].
    Cai XK; Zhou JL; Zhou HJ; Zhang L; Wu JH; Lin JS
    Ai Zheng; 2006 Nov; 25(11):1334-9. PubMed ID: 17094897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of adenovirus-mediated TK/GCV gene therapy in combination with TNF-alpha against murine bladder cancer cells in vitro].
    Shi XH; Tan WL; Zhu WH; Liang ZK; DU YJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):750-3. PubMed ID: 18504196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suicide gene therapy of human breast cancer in SCID mice model by the regulation of Tet-On.
    Hu WX; Zeng ZJ; Luo SQ; Chen Q
    Chin Med J (Engl); 2004 Mar; 117(3):434-9. PubMed ID: 15043787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lethal effect of adenovirus-mediated HSV-TK gene in combination with hydroxycamptothecin on human bladder cancer in vitro].
    Huang H; Tan WL; Zhu WH; Liang ZK
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):461-4. PubMed ID: 17545031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular localization and sustained prodrug cell killing activity of TAT-HSVTK fusion protein in hepatocelullar carcinoma cells.
    Cao L; Si J; Wang W; Zhao X; Yuan X; Zhu H; Wu X; Zhu J; Shen G
    Mol Cells; 2006 Feb; 21(1):104-11. PubMed ID: 16511352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of cell death induced by suicide genes encoding purine nucleoside phosphorylase and thymidine kinase in human hepatocellular carcinoma cells in vitro.
    Krohne TU; Shankara S; Geissler M; Roberts BL; Wands JR; Blum HE; Mohr L
    Hepatology; 2001 Sep; 34(3):511-8. PubMed ID: 11526536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: implications for pharmacogene therapy.
    Frank S; Steffens S; Fischer U; Tlolko A; Rainov NG; Kramm CM
    Cancer Gene Ther; 2002 Feb; 9(2):178-88. PubMed ID: 11857036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.